The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.
New horizons in tumor microenvironment biology: challenges and opportunities
Open accessAbstract
The tumor microenvironment (TME) is being increasingly recognized as a key factor in multiple stages of disease progression, particularly local resistance, immune-escaping, and distant metastasis, thereby substantially impacting the future development of frontline interventions in clinical oncology. An appropriate understanding of the TME promotes evaluation and selection of candidate agents to control malignancies at both the primary sites as well as the metastatic settings. This review presents a timely outline of research advances in TME biology and highlights the prospect of targeting the TME as a critical strategy to overcome acquired resistance, prevent metastasis, and improve therapeutic efficacy. As benign cells in TME niches actively modulate response of cancer cells to a broad range of standard chemotherapies and targeted agents, cancer-oriented therapeutics should be combined with TME-targeting treatments to achieve optimal clinical outcomes. Overall, a body of updated information is delivered to summarize recently emerging and rapidly progressing aspects of TME studies, and to provide a significant guideline for prospective development of personalized medicine, with the long term aim of providing a cure for cancer patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“As a result, solid tumors are inherently heterogeneous and structurally complex [18].”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [18]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
The blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838 · cited 1×
“For example, T cell activation involves both positive and negative checkpoint signals to finely tune responses to prevent excessive pathological changes [17,18].”
BackgroundMicroenvironmental regulation of tumor progression and metastasis
Quail, D. F., & Joyce, J. A. (2013) · Nature Medicine · doi:10.1038/nm.3394 · Cited by 7,994 · cited 1×
“Tumor dormancy is regulated by several mechanisms, driven partially by the TME, including cellular dormancy (cells arrested in G0), tumor mass dormancy (proliferation refrained by apoptosis), or immune dormancy (an equilibrium maintained by immunosurveillance) [92].”
BackgroundThe distribution of secondary growths in cancer of the breast.
Paget, S. (1889) · The Lancet · doi:10.1016/s0140-6736(00)49915-0 · Cited by 5,277
The immune contexture in human tumours: impact on clinical outcome
Fridman, W. H., Pagès, F., Sautès-Fridman, C., & Galon, J. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3245 · Cited by 4,981 · cited 2×
“For instance, when defining predictive markers that will eventually aid in the selection of patients who most likely benefit from intervention, analysis based on the entire TME is an essential step of utmost importance to determine specific therapies to employ [17,103,104].”
BackgroundCancer drug resistance: an evolving paradigm
Holohan, C., Van Schaeybroeck, S., Longley, D. B., & Johnston, P. G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3599 · Cited by 4,681 · cited 1×
“TME-mediated resistance can be initiated by multiple cell lineages and structural components in the stroma, including but not limited to fibroblasts, endothelial cells, pericytes, smooth muscle cells, neutrophils, macrophages, integrins, fibronectins, and collagens [26,30].”
BackgroundTumor-Associated Macrophages: From Mechanisms to Therapy
Noy, R., & Pollard, J. W. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.010 · Cited by 4,089 · cited 1×
“Furthermore, type II tumor-associated macrophages (TAMs) drastically affect tumorigenesis, angiogenesis, and intravasation, and can prevent immune attack by natural killer (NK) and T cells during tumor development and after recovery from chemo- and/or immunotherapy [23].”
BackgroundTumor Metastasis: Molecular Insights and Evolving Paradigms
Valastyan, S., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.09.024 · Cited by 4,011 · cited 2×
“Metastasis accounts for approximately 90% of overall mortality among solid tumor patients [78].”
BackgroundMelanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET
Peinado, H., Alečković, M., Lavotshkin, S., Matei, I., Costa-Silva, B., Moreno-Bueno, G., Hergueta-Redondo, M., Williams, C., García-Santos, G., Ghajar, C. M., et al. (2012) · Nature Medicine · doi:10.1038/nm.2753 · Cited by 3,715 · cited 1×
“As supporting evidence, several studies demonstrated that exosomes derived from BM-MSCs can induce progenitor cells to undergo mesenchymal-to-epithelial transition (MET), indicating active message delivery between cancer cells and the bone marrow TME [72,73].”
Cancer stem cells in solid tumours: accumulating evidence and unresolved questions
Visvader, J. E., & Lindeman, G. J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2499 · Cited by 3,429 · cited 1×
“In such cases, CSCs represent the potential source of eventual tumor relapse following therapy, which are typically therapy-resistant due to decreased oxidative stress response, increased genomic stability, and expression of multiple drug resistance transporters [35].”
BackgroundInfluential
Research works printed but not linked: 1
- Paget S. The distribution of secondary growths in cancer of the breast. 1889. Canc Metastasis Rev. 1989;8:98–101.
Cited by
Mao, X., Xu, J., Wang, W., Liang, C., Hua, J., Liu, J., Zhang, B., Meng, Q., Yu, X., & Shi, S. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01428-1 · Cited by 2,290
Role of hypoxia in cancer therapy by regulating the tumor microenvironment
Jing, X., Yang, F., Shao, C., Wei, K., Xie, M., Shen, H., & Shu, Y. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1089-9 · Cited by 2,054
“The TME decreases drug penetration and confers the advantage of proliferation and antiapoptosis to surviving cells, facilitating resistance and common modifications in disease morphology [4, 5].”
BackgroundThe Science and Translation of Lactate Shuttle Theory
Brooks, G. A. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.03.008 · Cited by 1,486
“Lactate Influences Acidity of the Tumor Microenvironment (TME) The TME is an active niche that shapes tumor pathogenesis and evolution (Chen et al., 2015).”
BackgroundRole of tumor microenvironment in tumorigenesis
Wang, M., Zhao, J., Zhang, L., Wei, F., Lian, Y., Wu, Y., Gong, Z., Zhang, S., Zhou, J., Cao, K., et al. (2017) · Journal of Cancer · doi:10.7150/jca.17648 · Cited by 1,404
Arneth, B. (2019) · Medicina · doi:10.3390/medicina56010015 · Cited by 1,250
“For instance, understanding the role of the naïve stroma will help caregivers determine how the TME influences the physiological homeostasis of normal tissues [12,14,15].”
Background
Metadata
- Authors
- Chen, F., Zhuang, X., Lin, L., Yu, P., Wang, Y., Shi, Y., Hu, G., & Sun, Y.
- Affiliations
- Shanghai Jiao Tong University (CN)
- Corresponding author
- Sun, Yu
- Venue
- BMC Medicine
- Published
- 2015-03-05
- Volume
- 13
- Issue
- 1
- Pages
- 45-45
- ISSN
- 1741-7015 (ISSN-L)
- PMC
- PMC4350882
- OpenAlex
- W2127686099
- Semantic Scholar
- b55be59deaf313855dba891ef8ed0f4aadc7f777
- Cited by
- 704
- References
- 105
- Citations by year
- 2026: 24 · 2025: 49 · 2024: 63 · 2023: 76 · 2022: 79 · 2021: 98 · 2020: 83 · 2019: 65 · 2018: 64 · 2017: 47 · 2016: 37 · 2015: 19
- FWCI
- 5.99
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- BMC Medicine (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Defense (PC111703)
- University of Washington (WA 98195)
- National Natural Science Foundation of China (81330046, 81472709, 31371409)
- Chinese Academy of Sciences (215123, XDA01040107, XDA01040110)
- Soochow University (215123)
- Shanghai Rising-Star Program
- Directorate for Biological Sciences
- School of Medicine, Shanghai Jiao Tong University
- Congressionally Directed Medical Research Programs
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Keywords
- tumor microenvironment, acquired drug resistance, immune evasion, metastasis, cancer immunotherapy, chemoresistance, personalized medicine, cancer therapy
- MeSH terms
- Humans, Medical Oncology, Neoplasms, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: New horizons in tumor microenvironment biology: challenges and opportunities. https://app.cochat.ai/papers/10.1186/s12916-015-0278-7
- The paper
- Chen, F., Zhuang, X., Lin, L., Yu, P., Wang, Y., Shi, Y., Hu, G., & Sun, Y. (2015). New horizons in tumor microenvironment biology: challenges and opportunities. BMC Medicine. https://doi.org/10.1186/s12916-015-0278-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.